InvestorsHub Logo
Followers 30
Posts 4823
Boards Moderated 0
Alias Born 01/21/2009

Re: Mr. Mercedes post# 49100

Wednesday, 11/18/2020 6:54:34 AM

Wednesday, November 18, 2020 6:54:34 AM

Post# of 54910
Conclusions: The overlap between DDR genes responding to ATRN-119 and those mutated in endometriosis-associated cancer suggest that genetic markers underlying response and resistance will be critical to extend the use of these drugs while increasing efficacy and minimizing toxicities. Furthermore, our data support the inclusion of endometriosis-associated cancer patients in planned ATRN-119 clinical trials.